Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Gerson D Keppeke

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
The FEBS Journal|August 8, 2018
Interfilament interaction between IMPDH and CTPS cytoophidiaChia-Chun Chang, Gerson D Keppeke, Li-Ying Sung, et al.
Frontiers in Immunology|February 21, 2015
Anti-rods/rings: a human model of drug-induced autoantibody generationS John Calise, Gerson D Keppeke, Luis E C Andrade, et al.
Cellular and Molecular Life Sciences : CMLS|May 8, 2024
The IMPDH cytoophidium couples metabolism and fetal development in miceMin Peng, Gerson D Keppeke, Li-Kuang Tsai, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 6, 2021
Serum Myostatin and Follistatin Levels in Patients With Dermatomyositis and PolymyositisCintia M de Sordi, Edgard T Dos Reis-Neto, Gerson D Keppeke, et al.
Journal of Circulating Biomarkers|November 28, 2025
Anti-CENP-A/B reactivity in samples exhibiting the centromere HEp-2 pattern is associated with a lower frequency of interstitial lung disease in limited cutaneous systemic sclerosis patientsGerson D Keppeke, Diana Landoni, Cristiane Kayser, et al.
Pigment Cell & Melanoma Research|December 29, 2019
IMP dehydrogenase rod/ring structures in acral melanomasGerson D Keppeke, Denise Barcelos, Mariana Fernandes, et al.
Frontiers in Immunology|January 31, 2022
Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot StudyThais G Moreira, Kimble T F Matos, Giovana S De Paula, et al.
Frontiers in Immunology|September 3, 2021
Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot StudyThais G Moreira, Kimble T F Matos, Giovana S De Paula, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
The FEBS Journal|August 8, 2018
Interfilament interaction between IMPDH and CTPS cytoophidiaChia-Chun Chang, Gerson D Keppeke, Li-Ying Sung, et al.
Frontiers in Immunology|February 21, 2015
Anti-rods/rings: a human model of drug-induced autoantibody generationS John Calise, Gerson D Keppeke, Luis E C Andrade, et al.
Cellular and Molecular Life Sciences : CMLS|May 8, 2024
The IMPDH cytoophidium couples metabolism and fetal development in miceMin Peng, Gerson D Keppeke, Li-Kuang Tsai, et al.
Journal of Clinical Rheumatology : Practical Reports on Rheumatic & Musculoskeletal Diseases|November 6, 2021
Serum Myostatin and Follistatin Levels in Patients With Dermatomyositis and PolymyositisCintia M de Sordi, Edgard T Dos Reis-Neto, Gerson D Keppeke, et al.
Journal of Circulating Biomarkers|November 28, 2025
Anti-CENP-A/B reactivity in samples exhibiting the centromere HEp-2 pattern is associated with a lower frequency of interstitial lung disease in limited cutaneous systemic sclerosis patientsGerson D Keppeke, Diana Landoni, Cristiane Kayser, et al.
Pigment Cell & Melanoma Research|December 29, 2019
IMP dehydrogenase rod/ring structures in acral melanomasGerson D Keppeke, Denise Barcelos, Mariana Fernandes, et al.
Frontiers in Immunology|January 31, 2022
Corrigendum: Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot StudyThais G Moreira, Kimble T F Matos, Giovana S De Paula, et al.
Frontiers in Immunology|September 3, 2021
Nasal Administration of Anti-CD3 Monoclonal Antibody (Foralumab) Reduces Lung Inflammation and Blood Inflammatory Biomarkers in Mild to Moderate COVID-19 Patients: A Pilot StudyThais G Moreira, Kimble T F Matos, Giovana S De Paula, et al.
Pageof 1